These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chains. Lynch CL; Willoughby CA; Hale JJ; Holson EJ; Budhu RJ; Gentry AL; Rosauer KG; Caldwell CG; Chen P; Mills SG; MacCoss M; Berk S; Chen L; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA Bioorg Med Chem Lett; 2003 Jan; 13(1):119-23. PubMed ID: 12467630 [TBL] [Abstract][Full Text] [Related]
6. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements. Hale JJ; Budhu RJ; Mills SG; MacCoss M; Malkowitz L; Siciliano S; Gould SL; DeMartino JA; Springer MS Bioorg Med Chem Lett; 2001 Jun; 11(11):1437-40. PubMed ID: 11378372 [TBL] [Abstract][Full Text] [Related]
7. Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor. Shankaran K; Donnelly KL; Shah SK; Guthikonda RN; MacCoss M; Mills SG; Gould SL; Malkowitz L; Siciliano SJ; Springer MS; Carella A; Carver G; Hazuda D; Holmes K; Kessler J; Lineberger J; Miller MD; Emini EA; Schleif WA Bioorg Med Chem Lett; 2004 Jul; 14(13):3419-24. PubMed ID: 15177445 [TBL] [Abstract][Full Text] [Related]
8. CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives. Imamura S; Ishihara Y; Hattori T; Kurasawa O; Matsushita Y; Sugihara Y; Kanzaki N; Iizawa Y; Baba M; Hashiguchi S Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):63-73. PubMed ID: 14709870 [TBL] [Abstract][Full Text] [Related]
9. CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines. Lynch CL; Gentry AL; Hale JJ; Mills SG; MacCoss M; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Doss G; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA Bioorg Med Chem Lett; 2002 Feb; 12(4):677-9. PubMed ID: 11844699 [TBL] [Abstract][Full Text] [Related]
10. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides. McCombie SW; Tagat JR; Vice SF; Lin SI; Steensma R; Palani A; Neustadt BR; Baroudy BM; Strizki JM; Endres M; Cox K; Dan N; Chou CC Bioorg Med Chem Lett; 2003 Feb; 13(3):567-71. PubMed ID: 12565973 [TBL] [Abstract][Full Text] [Related]
11. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes. Dorn CP; Finke PE; Oates B; Budhu RJ; Mills SG; MacCoss M; Malkowitz L; Springer MS; Daugherty BL; Gould SL; DeMartino JA; Siciliano SJ; Carella A; Carver G; Holmes K; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Schleif WA; Emini EA Bioorg Med Chem Lett; 2001 Jan; 11(2):259-64. PubMed ID: 11206473 [TBL] [Abstract][Full Text] [Related]
12. Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties. Kim D; Wang L; Hale JJ; Lynch CL; Budhu RJ; Maccoss M; Mills SG; Malkowitz L; Gould SL; DeMartino JA; Springer MS; Hazuda D; Miller M; Kessler J; Hrin RC; Carver G; Carella A; Henry K; Lineberger J; Schleif WA; Emini EA Bioorg Med Chem Lett; 2005 Apr; 15(8):2129-34. PubMed ID: 15808483 [TBL] [Abstract][Full Text] [Related]
13. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives. Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561 [TBL] [Abstract][Full Text] [Related]
14. Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety. Shiraishi M; Aramaki Y; Seto M; Imoto H; Nishikawa Y; Kanzaki N; Okamoto M; Sawada H; Nishimura O; Baba M; Fujino M J Med Chem; 2000 May; 43(10):2049-63. PubMed ID: 10821717 [TBL] [Abstract][Full Text] [Related]
16. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes. Finke PE; Meurer LC; Oates B; Mills SG; MacCoss M; Malkowitz L; Springer MS; Daugherty BL; Gould SL; DeMartino JA; Siciliano SJ; Carella A; Carver G; Holmes K; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Schleif WA; Emini EA Bioorg Med Chem Lett; 2001 Jan; 11(2):265-70. PubMed ID: 11206474 [TBL] [Abstract][Full Text] [Related]
17. Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents. Li B; Jones ED; Zhou E; Chen L; Baylis DC; Yu S; Wang M; He X; Coates JA; Rhodes DI; Pei G; Deadman JJ; Xie X; Ma D Bioorg Med Chem Lett; 2010 Sep; 20(17):5334-6. PubMed ID: 20674358 [TBL] [Abstract][Full Text] [Related]
18. Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. Nishizawa R; Nishiyama T; Hisaichi K; Matsunaga N; Minamoto C; Habashita H; Takaoka Y; Toda M; Shibayama S; Tada H; Sagawa K; Fukushima D; Maeda K; Mitsuya H Bioorg Med Chem Lett; 2007 Feb; 17(3):727-31. PubMed ID: 17118654 [TBL] [Abstract][Full Text] [Related]
19. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes. Finke PE; Meurer LC; Oates B; Shah SK; Loebach JL; Mills SG; MacCoss M; Castonguay L; Malkowitz L; Springer MS; Gould SL; DeMartino JA Bioorg Med Chem Lett; 2001 Sep; 11(18):2469-73. PubMed ID: 11549449 [TBL] [Abstract][Full Text] [Related]
20. Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides. Palani A; Shapiro S; Clader JW; Greenlee WJ; Vice S; McCombie S; Cox K; Strizki J; Baroudy BM Bioorg Med Chem Lett; 2003 Feb; 13(4):709-12. PubMed ID: 12639564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]